PrairieView Partners’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Hold |
5,000
| – | – | ﹤0.01% | 212 |
|
|
2025
Q1 | $14K | Hold |
5,000
| – | – | ﹤0.01% | 262 |
|
|
2024
Q4 | $23K | Hold |
5,000
| – | – | ﹤0.01% | 236 |
|
|
2024
Q3 | $17K | Hold |
5,000
| – | – | ﹤0.01% | 257 |
|
|
2024
Q2 | $31K | Hold |
5,000
| – | – | ﹤0.01% | 231 |
|
|
2024
Q1 | $48K | Hold |
5,000
| – | – | 0.01% | 192 |
|
|
2023
Q4 | $34K | Hold |
5,000
| – | – | ﹤0.01% | 202 |
|
|
2023
Q3 | $22K | Hold |
5,000
| – | – | ﹤0.01% | 236 |
|
|
2023
Q2 | $16K | Buy |
5,000
+1,400
| +39% | +$4.48K | ﹤0.01% | 285 |
|
|
2023
Q1 | $10K | Hold |
3,600
| – | – | ﹤0.01% | 304 |
|
|
2022
Q4 | $26K | Hold |
3,600
| – | – | ﹤0.01% | 236 |
|
|
2022
Q3 | $29K | Buy |
3,600
+1,400
| +64% | +$11.3K | ﹤0.01% | 222 |
|
|
2022
Q2 | $11K | Buy |
2,200
+1,700
| +340% | +$8.5K | ﹤0.01% | 318 |
|
|
2022
Q1 | $12K | Buy |
500
+300
| +150% | +$7.2K | ﹤0.01% | 311 |
|
|
2021
Q4 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 364 |
|